Eribulin Mesylate 0.44 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 0.44 mg/mL
Reference Brands: HALAVEN (USA/EU)
Category: Oncology Cancer Care
Eribulin mesylate is a microtubule dynamics inhibitor derived from the marine sponge Halichondria okadai. It is used for the treatment of patients with metastatic breast cancer and unresectable or metastatic liposarcoma who have received prior chemotherapy. The drug works by inhibiting microtubule growth, leading to cancer cell cycle arrest and apoptosis. Halaven is administered intravenously under medical supervision and is recognized for extending survival in patients with advanced cancer.
Eribulin Mesylate — third party manufacturing & bulk supply
Eribulin Mesylate 0.44 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Eribulin Mesylate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Eribulin Mesylate →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Eribulin mesylate is used to treat patients with metastatic breast cancer and unresectable or metastatic liposarcoma who have received prior chemotherapy. It works by inhibiting microtubule dynamics in cancer cells, which leads to cell cycle arrest and apoptosis, helping to slow or stop tumor growth.
Eribulin mesylate is made from a synthetic analog of halichondrin B, a compound originally derived from the marine sponge Halichondria okadai. It is a microtubule dynamics inhibitor that targets cancer cells.
The trade name of Eribulin mesylate is Halaven.
Eribulin mesylate (Halaven) is manufactured by Eisai Co., Ltd. and marketed globally in collaboration with other licensed pharmaceutical distributors.
The generic name of Eribulin mesylate is Eribulin mesylate.
The brand name of Eribulin mesylate is Halaven.
Eribulin mesylate is manufactured in Japan and other countries by Eisai Co., Ltd. under strict GMP-certified conditions for oncology therapeutics.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
